Oncology Overview: Lenvatinib (Lenvima) for Multiple Cancer Types - Pharmacy Times

Lenvima (lenvatinib) is approved for the treatment of thyroid cancer, renal cell carcinoma, hepatocellular carcinoma, and endometrial carcinoma.

Introduction Lenvima (lenvatinib) is a kinase-inhibiting medication FDA-approved for the treatment of the following cancers:1

• Differentiated thyroid cancer (DTC) as a single agent to treat … [+3722 chars]
  full article...